Physiomics Statistics
Total Valuation
Physiomics has a market cap or net worth of EUR 1.29 million. The enterprise value is 768,744.
| Market Cap | 1.29M |
| Enterprise Value | 768,744 |
Important Dates
The next estimated earnings date is Thursday, December 4, 2025.
| Earnings Date | Dec 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 303.21M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +75.94% |
| Shares Change (QoQ) | +37.85% |
| Owned by Insiders (%) | 5.47% |
| Owned by Institutions (%) | 81.51% |
| Float | 268.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.33 |
| PB Ratio | 1.60 |
| P/TBV Ratio | 1.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.59 |
| EV / Sales | 0.81 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.20 |
Financial Position
The company has a current ratio of 4.38
| Current Ratio | 4.38 |
| Quick Ratio | 3.82 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -85.21% and return on invested capital (ROIC) is -58.17%.
| Return on Equity (ROE) | -85.21% |
| Return on Assets (ROA) | -43.30% |
| Return on Invested Capital (ROIC) | -58.17% |
| Return on Capital Employed (ROCE) | -65.79% |
| Revenue Per Employee | 97,313 |
| Profits Per Employee | -48,444 |
| Employee Count | 10 |
| Asset Turnover | 1.27 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -49,015 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.00% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -75.00% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 32.58 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Physiomics had revenue of EUR 973,125 and -484,435 in losses. Loss per share was -0.00.
| Revenue | 973,125 |
| Gross Profit | -507,560 |
| Operating Income | -531,257 |
| Pretax Income | -533,449 |
| Net Income | -484,435 |
| EBITDA | -520,684 |
| EBIT | -531,257 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 538,084 in cash and n/a in debt, giving a net cash position of 538,084.
| Cash & Cash Equivalents | 538,084 |
| Total Debt | n/a |
| Net Cash | 538,084 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 807,485 |
| Book Value Per Share | 0.00 |
| Working Capital | 788,727 |
Cash Flow
In the last 12 months, operating cash flow was -637,129 and capital expenditures -4,591, giving a free cash flow of -641,720.
| Operating Cash Flow | -637,129 |
| Capital Expenditures | -4,591 |
| Free Cash Flow | -641,720 |
| FCF Per Share | n/a |
Margins
Gross margin is -52.16%, with operating and profit margins of -54.59% and -49.78%.
| Gross Margin | -52.16% |
| Operating Margin | -54.59% |
| Pretax Margin | -54.82% |
| Profit Margin | -49.78% |
| EBITDA Margin | -53.51% |
| EBIT Margin | -54.59% |
| FCF Margin | n/a |
Dividends & Yields
Physiomics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -75.94% |
| Shareholder Yield | -75.94% |
| Earnings Yield | -37.45% |
| FCF Yield | -49.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Physiomics has an Altman Z-Score of -7.77 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.77 |
| Piotroski F-Score | 2 |